← Back to signals
BSX
STRONG BUYBoston Scientific Corporation
Health Care
0.45
PEGY ratio
Rank #179
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 58.0% annually over 5 years.
BSX is trading at 26.0x earnings against 58.0% growth (no dividend), giving a PEGY of 0.45. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-04-24
Valuation
26.0x
P/E Ratio
Growth
58.0%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score0.45
Denominator58.0%
EPS (TTM)$2.39
Market Data
Price$62.07
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.33→0.45(+0.12)
Rank
#84→#179(95 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only